Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
LG Chem to Sell LG Energy Solution Shares for 2.5 Trillion Won

LG Chem to Sell LG Energy Solution Shares for 2.5 Trillion Won

BitgetBitget2026/10/28 06:51
  • LG Chem plans to sell 6,535,939 LG Energy Solution common shares for KRW 2.5 trillion to improve finances and enhance shareholder value.
  • The indicative price is KRW 382,500 per share; the final price and share count may change.
  • The sale is scheduled for Nov. 27-Dec. 24, 2026.
  • Its remaining holding will total 179,211,586 shares, representing a 76.59% stake.
  • A two-year price return swap (PRS) will settle differences between the buyer's resale proceeds and the shares' reference value.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LG Chem Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261028800407), on October 28, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs comments on AMD (AMD.US) Q3 performance: Data center CPU and GPU show strong performance, growth visibility for 2027 is clear

Goldman Sachs released a research report maintaining a "Buy" rating on AMD (AMD.US) with a 12-month target price of $675.

智通财经•2026/11/04 03:53

AbbVie (ABBV.US) expands Oxford R&D facility in UK, betting on innovation in immunology, neuroscience, and oncology drugs

AbbVie announced on Wednesday that, as part of an investment plan exceeding 120 million pounds (approximately $161 million), the company has expanded its research and development facility in Oxford, United Kingdom.

智通财经•2026/11/04 02:51